Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Giant cell arteritis
Questions discussed in this category
How do you manage a patient with giant cell arteritis treated with weekly tocilizumab and low dose glucocorticoid who develops sudden vision loss?
2 Answers available
Can giant cell arteritis present with a partial cranial neuropathy?
3 Answers available
Do you generally recommend low dose aspirin for patients with giant cell arteritis?
2 Answers available
What lab markers are helpful for monitoring polymyalgia rheumatica patients on tocilizumab?
Since tocilizumab is known to normalize ESR/CRP, are there any markers/blood tests that may be helpful to check for PMR patients with question of exac...
1 Answer available
How long do you continue steroid-sparing agents such as tocilizumab for GCA once the disease is in remission off steroids?
1 Answer available
Do you monitor RS3PE patients for GCA with the same vigilance that you do in PMR patients?
1 Answer available
What do you use to treat a GCA patient refractory to methotrexate who responded but had adverse effects with both tocilizumab and sarilumab?
1 Answer available
12639
12036
12443
11887
8388
8416
8014
Papers discussed in this category
Ann Intern Med, 2020 Sep 22
Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis : A Cohort Study.
Rheumatol Ther, 2021 Mar 21
Inflammatory Markers are Quickly Improved by Tocilizumab in Early Polymyalgia Rheumatica and Might Predict Early Response to Interleukin-6 Blockade.
Arthritis Rheum,
Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis.
Arthritis Res Ther, 2021 Mar 22
Vision loss in patients with giant cell arteritis treated with tocilizumab.
Related Topics
Rheumatology
Vasculitis
Tocilizumab
GCA
Large vessel vasculitis
Polymyalgia rheumatica
Neurology
Maintenance therapy
RS3PE
PMR